Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00102869
Status:
COMPLETED
Last Update Posted:
2013-10-07
First Post:
2005-02-03
Brief Title:
Dopaminergic Enhancement of Learning and Memory in Aphasia
Sponsor:
University Hospital Muenster
Organization:
University Hospital Muenster
Study Overview
Official Title:
Dopaminergic Enhancement of Learning and Memory LL_001 Project on Aphasia
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether levodopa in combination with a high frequency language training is effective in boosting naming performance in patients with aphasia
Detailed Description:
Our prior work shows that d-amphetamine and the dopamine precursor levodopa markedly improve word learning success in healthy subjects In this randomized placebo-controlled double-blind clinical trial we probe whether daily administration of levodopa coupled with several hours of language training every day will significantly improve naming abilities in patients with aphasia as compared to placebo administration We furthermore examine with magnetic resonance imaging which brain regions need to be functionally intact for a dopaminergic improvement of language therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None